RankingsPricing
  1. JP-listed companies
  2. HABA LABORATORIES, INC.
  3. Financials
  4. Cash and cash equivalents

HABA LABORATORIES, INC.JP:4925

Market cap
¥6.6B
P/E ratio
13.1x
SummaryFinancialsHistoryOwnershipWorkforce
Period EndCash and cash equivalents (Million JPY)YoY (%)
Mar 31, 20254,744+19.81%
Mar 31, 20243,959-17.82%
Mar 31, 20234,818-14.75%
Mar 31, 20225,651-0.22%
Mar 31, 20215,664+8.33%
Mar 31, 20205,228-11.72%
Mar 31, 20195,922+17.40%
Mar 31, 20185,045+35.45%
Mar 31, 20173,725-2.75%
Mar 31, 20163,830+1.95%
Mar 31, 20153,757

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)